Not Signed In -
Prednisone |
|
|
Prednisone Systematic (IUPAC) name 17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl- 7,8,9,10,12,13,14,15,16,17-decahydro-6H- cyclopenta[a]phenanthrene-3,11-dione Identifiers CAS number 53-03-2 ATC code A07EA03 H02AB07 PubChem 5865 DrugBank APRD00340 Chemical data Formula C21H26O5 Mol. weight 358.428 g/mol Pharmacokinetic data Bioavailability 70% Metabolism prednisolone (liver) Half life 1 hour Excretion Renal Therapeutic considerations Pregnancy cat. ...
Wikipedia - [full article]
Prednisone News Headlines
- Taxotere® (docetaxel) Significantly Improves The Survival Of Patients With Advanced Prostate Cancer
MedicalNewsToday - Mon, 26 Feb 2007 08:00 EST
- Weekly Docetaxel And Prednisolone Versus Prednisolone Alone In Androgen-Independent Prostate Cancer: A Randomized Phase II Study
MedicalNewsToday - Mon, 05 Mar 2007 08:00 EST
- Spectrum Pharmaceuticals Announces Satraplatin Data Presentation At The American Society Of Clinical Oncology Prostate Cancer Symposium
MedicalNewsToday - Sat, 24 Feb 2007 08:00 EST
- Study Showed Epratuzumab In Combination With Rituximab And Chemotherapy Is Safe, Tolerable, And Active In Aggressive Lymphoma
MedicalNewsToday - Tue, 05 Dec 2006 08:00 EST
- SkyePharma Reports Positive Phase III And EU Filing For Lodotra(TM)
MedicalNewsToday - Thu, 05 Oct 2006 07:00 EST
- Pharmion Corporation And GPC Biotech Announce Positive Results From The Satraplatin Pivotal Phase 3
MedicalNewsToday - Mon, 25 Sep 2006 07:00 EST
- Four-drug strategy reduces repeat miscarriages
Reuters - Thu, 27 Jul 2006 07:39 EST
- Spectrum Pharmaceuticals Announces Submission Of Non-Clinical Section Of Rolling NDA For Satraplatin
MedicalNewsToday - Fri, 14 Jul 2006 06:00 EST
- VELCADE(R) (Bortezomib) For Injection Showed Unprecedented Results In Newly Diagnosed Multiple Myeloma Patients
MedicalNewsToday - Thu, 22 Jun 2006 06:00 EST
- Independent Data Monitoring Board Recommends Expedited Interim Analysis Of Overall Survival Data For Satraplatin Phase 3 Trial
MedicalNewsToday - Thu, 18 May 2006 06:00 EST
- Independent Data Monitoring Board Recommends Expedited Interim Analysis Of Overall Survival Data For Satraplatin Phase 3 Trial
MedicalNewsToday - Thu, 18 May 2006 06:00 EST
- Supplemental Biologics License Application For First-Line Use Of Rituxan In Low-Grade Or Follicular CD20-Positive B-Cell Non-Hodgkin's Lymphoma
MedicalNewsToday - Sat, 01 Apr 2006 11:00 EST
- Steroid treatment for arthritis ups pneumonia risk
Reuters - Thu, 16 Mar 2006 05:21 EST
email this page
print this page
bookmark this page
feedback on this page
